Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia
Clinical trial NCT02877303 · RECRUITING
Trial details
- NCT number
- NCT02877303
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2026-11-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.